COMMUNIQUÉS West-GlobeNewswire

Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
14/10/2025
PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune [...]
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema
14/10/2025
– DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New preclinical data [...]
Inventiva Announces the Implementation of a New ATM Program
14/10/2025
Daix (France), New York City (New York, United States), October 14, 2025 – Inventiva (Euronext Paris and Nasdaq : IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]
Inventiva annonce la mise en place d’un nouveau programme « At-The-Market » (ATM)
14/10/2025
Daix (France), New York City (New York, Etats-Unis), le 14 octobre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Oral GLP-1 Tablets Gain Momentum as Telehealth Platform MEDVi Expands Access to Compounded Semaglutide and Tirzepatide for Physician-Supervised Weight Management
14/10/2025
Needle-Free Compounded Semaglutide and Tirzepatide Tablets Offer Physician-Supervised, At-Home GLP-1 Treatment Access Through MEDVi’s Nationwide Telehealth Platform Los Angeles, Oct. 14, 2025 (GLOBE NEWSWIRE) -- [...]
EmblemHealth Achieves 4-Star Medicare Rating, Highlighting Sustained Quality Improvements
14/10/2025
Defying national trends in downward Medicare Advantage ratings for not-for-profit health plans, EmblemHealth increased its Medicare Star rating for the second consecutive year. NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE [...]
Breakthrough in Obesity Solutions: Fuzzle’s Non-Invasive Oral Device Begins FDA Review Process
14/10/2025
Dover, DE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- In a major step forward for obesity solutions, Fuzzle, a pioneering health technology company, announced today that its innovative oral device has officially entered the U.S [...]
Nova Leap Health Corp. to Highlight Record Q2 2025 Results at Planet MicroCap Showcase Toronto
14/10/2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Oct. 14, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]

Pages